Editas stock price target

Jan 01, 2010 · Editas Medicine (NASDAQ: EDIT) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Editas Medicine (NASDAQ:EDIT) Stock Price Down 6% ... Editas Medicine (NASDAQ:EDIT) Stock Price Down 6% Zacks Investment Research raised Editas Medicine from a “hold” rating to a “buy” rating and set a … Analysts Turn Mixed On ResMed Inc. (NYSE:RMD), Editas ... Mar 05, 2020 · That day the UBS set price target on the stock to $174. KeyBanc Capital Markets was of a view that RMD is Sector Weight in its latest report on November 22, 2019. UBS thinks that RMD is worth Buy rating. This was contained in the firm’s report on July 29, 2019 in which the stock’s price target was also moved to 140. Questions Remain, But Analysts Stay Bullish: Guardant ... Editas Medicine (EDIT) Intraday View. Based on the latest results, analysts are suggesting that the target price for EDIT stock should be $22.41 per share in the course of the next 12 months. To achieve the target price as suggested by analysts, EDIT should have a spike by 0% in oppose to its present value in the market.

Editas Medicine (NASDAQ:EDIT) Stock Price Down 6% Zacks Investment Research raised Editas Medicine from a “hold” rating to a “buy” rating and set a …

EDIT - Editas Medicine Inc Stock quote - CNNMoney.com

Market cap of Editas Medicine Inc. [EDIT] reaches 1.23B ... The new note on the price target was released on April 12, 2019, representing the official price target for Editas Medicine Inc. stock. The Average True Range (ATR) for Editas Medicine Inc. is set at 1.33, with the Price to Sales ratio for EDIT stock in the period of the last 12 months amounting to 85.17. The Price to Book ratio for the last

Analyzing Editas Medicine (NASDAQ:EDIT) and AIM ImmunoTech ...

Stock Comparison: Compare Editas Medicine, Inc. (EDIT) to ...

BidaskClub upgraded shares of Editas Medicine (NASDAQ:EDIT) from a strong sell rating to a sell rating in a report issued on Friday, BidAskClub reports. Other equities analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Editas Medicine from a hold rating to a buy rating and set a […]

See Editas Medicine price target based on 7 analysts offering 12 month price targets for Editas Medicine in the last 3 months. The average price target is $36.80 with a high forecast of $55.00 and a low forecast of $28.00. The average price target represents a 98.92% increase from the last price of $18.50. Editas Medicine, Inc. Common Stock (EDIT) Stock Quotes ... Editas Medicine, Inc. Common Stock (EDIT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. EDIT Stock Price | Editas Medicine Inc. Stock Quote (U.S ... EDIT | Complete Editas Medicine Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.